So-Young International Inc. (SY)
NASDAQ: SY · IEX Real-Time Price · USD
1.300
0.00 (0.00%)
May 1, 2024, 3:20 PM EDT - Market open
So-Young International Revenue
In the year 2023, So-Young International had annual revenue of $211.29M with 17.08% growth. Revenue in the quarter ending December 31, 2023 was $55.09M with 18.09% year-over-year growth.
Revenue (ttm)
$211.29M
Revenue Growth
+17.08%
P/S Ratio
0.64
Revenue / Employee
$134,321
Employees
1,573
Market Cap
137.68M USD
Revenue Chart
* The company reports in CNY currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 211.29M | 30.82M | 17.08% |
Dec 31, 2022 | 180.47M | -83.98M | -31.76% |
Dec 31, 2021 | 264.45M | 66.44M | 33.55% |
Dec 31, 2020 | 198.01M | 33.49M | 20.36% |
Dec 31, 2019 | 164.52M | 75.20M | 84.18% |
Dec 31, 2018 | 89.32M | 50.13M | 127.89% |
Dec 31, 2017 | 39.20M | 32.08M | 450.93% |
Dec 31, 2016 | 7.11M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
InterCure | 112.41M |
Biodesix | 49.09M |
Scilex Holding Company | 46.74M |
Augmedix | 44.86M |
Zomedica | 25.19M |
Seer, Inc. | 16.66M |
Syros Pharmaceuticals | 9.94M |
MSP Recovery | 7.71M |
SY News
- 6 days ago - So-Young International Inc. Files Its Annual Report on Form 20-F - PRNewsWire
- 6 weeks ago - So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results - PRNewsWire
- 6 weeks ago - So-Young to Report Fourth Quarter and Full Year 2023 Financial Results on March 20, 2024 - PRNewsWire
- 4 months ago - So-Young Announces Update on Repurchase and Cancellation of Shares - PRNewsWire
- 4 months ago - Grant of Restricted Share Units to Mr. Xing Jin - PRNewsWire
- 5 months ago - So-Young Enters into Strategic Partnership with Healtech to Further Expand Supply Chain Business - PRNewsWire
- 5 months ago - So-Young Reports Unaudited Third Quarter 2023 Financial Results - PRNewsWire
- 6 months ago - So-Young's Subsidiary Wuhan Miracle Submits Application Documents for Initial Public Offering on China's Beijing Stock Exchange - PRNewsWire